PPBT Purple Biotech Ltd.
Healthcare$2.88+6.67%ClosedMarket Cap: $397,682
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.66
P/S
0.00
EV/EBITDA
0.48
DCF Value
$2,764.39
FCF Yield
-246.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-123.5%
ROA
-178.8%
ROIC
-302.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.3M | $-86.0K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.0M | $-23.7M | $— | — |
| FY null | $0.00 | NaN% | $-27.5M | $-26.4M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-1.4M | $-1.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.3M | $-1.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.4M | $-450.6K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-1.0M | $-410.0K | $— | — |
| FY null | $0.00 | -Infinity% | $-11.0M | $-7.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-2.1M | $-663.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-3.5M | $-2.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.5M | $-3.8M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.3M | $-4.8M | $-37.80 | — |